G. Kreutz

Placebo-controlled trials and the Declaration of Helsinki

John A. Lewis, C. Sampaio, B. Jonsson, 2002, The Lancet.

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

O. Johnell, J. Reginster, R. Rizzoli, 2005, Osteoporosis International.

Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.

J. Reginster, A. Laslop, P. Delmas, 2005, Seminars in arthritis and rheumatism.

Background for studies on the treatment of male osteoporosis: state of the art

O. Johnell, J. Reginster, J. Kaufman, 2000, Annals of the rheumatic diseases.

Adherence to treatment of osteoporosis: a need for study

J. Reginster, V. Rabenda, R. Rizzoli, 2007, Osteoporosis International.

Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Group for the Respect of Ethics and Excellence in Science (GREES): rheumatoid arthritis section.

P. Emery, D. Reid, U. Serni, 1998, British journal of rheumatology.